Return to search

IPO Profile: Kite Pharma Inc

Company Details

Location: 2225 Colorado Avenue, Santa Monica, California 90404

Phone: (310) 824-9999

Website: http://www.kitepharma.com

Investment & Return Details

Business Description: Kite Pharma Inc operates as a biotechnology company.

VC backers: Alta Partners, Pontifax Ltd

Investment Dates: 03/09/2011, 12/14/2012, 05/10/2013, 04/28/2014

Total Funding To Date (USD Mil): $97.7

Value of VCs’ shares at IPO price (USD Mil): $73.98

Total return to VCs at IPO price: 0.75x

Shares Beneficially owned by VCs at Offering:

  • Alta Partners: 2,158,545
  • Pontifax Ltd: 2,193,457
  • Total: 4,352,002

Value of VC shares at IPO price (USD Mil):

  • Alta Partners: $36.70
  • Pontifax Ltd: $37.29
  • Total: $73.98

IPO Details

Primary Exchange: Nasdaq

Ticker: KITE

Time to Exit (Years): 3.3

Date Filed: 05/19/2014

Date Issued: 06/19/2014

Offer Price (USD): $17.00

First Day Closing Price (USD): $29.00

No. of Shares Offered + Overallot Sold All Mkts: 8,625,000

Proceeds Amt + Overallot Sold All Markets (USD Mil): $127.50

Post Offer Value (USD Mil): $241.86

Issuer’s Legal Advisor: Cooley LLP

Book Runner: Cowen & Co, Credit Suisse Securities (USA) LLC, Jefferies LLC

Co-Managers: Stifel Nicolaus & Co Inc

Source: Thomson Reuters and company prospectus